COMMUNIQUÉS West-GlobeNewswire

MyoKardia to Present at 2019 Wedbush PacGrow Healthcare Conference
07/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will present at the 2019 Wedbush PacGrow Healthcare Conference [...]
scPharmaceuticals Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
Type C Meeting confirmed that FDA does not believe additional clinical safety, efficacy, or pharmacology studies will be required to support NDA resubmission Company successfully completed the first of two planned human [...]
Progressive Care Inc. Garners Coverage in Hispanic MPR Podcast
07/08/2019
MIAMI, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that Shital Mars, CEO of Progressive Care Inc., was featured on [...]
TYME Announces Abstracts Selected for Presentation at the AACR Special Conference on Pancreatic Cancer
07/08/2019
SM-88 (racemetyrosine) is an oral, investigational cancer metabolism-based therapy that has demonstrated responses across 15 different cancers New oral approach aimed at disrupting cancer metabolism in metastatic [...]
Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2019 Financial Results
07/08/2019
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer
07/08/2019
Dr. McHutchison is a world-renowned hepatologist, gastroenterologist, and anti-viral drug developer He led the research and development of five marketed therapies for chronic hepatitis B and chronic hepatitis C Succeeds [...]
Allena Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
-- Interim Data from Study 206 Demonstrated Substantial Treatment Effect in Patients with Enteric Hyperoxaluria and Advanced Chronic Kidney Disease, Including Robust Reductions in Both Urine and Plasma Oxalate -- -- [...]
NeuBase Therapeutics to Ring the NASDAQ Closing Bell Today
07/08/2019
PITTSBURGH, Aug. 07, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” and the “Company”), a biotechnology company developing next generation antisense therapies to address genetic diseases, [...]
aTyr Pharma to Announce Second Quarter 2019 Results on August 14th
07/08/2019
Company to host conference call and webcast at 5pm EDT / 2pm PDT SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of [...]
Neoleukin Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
07/08/2019
SEATTLE, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, and Aquinox [...]
Kura Oncology to Present at Wedbush PacGrow Healthcare Conference
07/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]
Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2019 Financial Results
07/08/2019
Conference Call and Webcast at 9 a.m. Eastern Time on August 14, 2019 NEWTOWN, Pa., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company focused on [...]
Affimed Reports Second Quarter 2019 Financial and Operational Results
07/08/2019
Heidelberg, Germany, August 7, 2019 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today reported financial and [...]
Cidara Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
07/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Jeffrey Stein, Ph.D., [...]
Eloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business Update
07/08/2019
Phase 2 cystic fibrosis clinical trial IND is open in the U.S., protocol endorsed by the Cystic Fibrosis Foundation (CFF) Initiated a Phase 2 clinical trial for ELX-02 in cystinosis in Canada and received non-dilutive [...]
Allogene Therapeutics Reports Second Quarter 2019 Financial Results
07/08/2019
ALLO-501 Phase 1 ALPHA Trial in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (NHL) Advances with Five Clinical Trial Sites Open Investigational New Drug (IND) Application Cleared by the U.S. Food & Drug [...]
CURE Pharmaceutical Expands Board with Two Women Directors
07/08/2019
OXNARD, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of two directors to its Board, Dr. Lauren Chung, Ph.D [...]
Indus Holdings, Inc. to Report Second Quarter 2019 Financial Results on August 21, 2019
07/08/2019
SALINAS, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically-integrated cannabis company, today announced that it plans to release its financial results for the [...]
Myriad Will Seek FDA Approval of BRACAnalysis CDx® As a Companion Diagnostic for Lynparza® (olaparib) In Men with Metastatic Castrate-Resistant Prostate Cancer
07/08/2019
SALT LAKE CITY, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, today announced that the AstraZeneca/Merck Phase III PROfound [...]

Pages